Image

OCT in Diagnosis of Irregular Corneas

OCT in Diagnosis of Irregular Corneas

Recruiting
14-85 years
All
Phase N/A

Powered by AI

Overview

This main goal of this study is to improve the detection, classification, monitoring, and treatment of irregular corneas due to keratoconus, warpage, dry eye, scar, stromal dystrophies, and other corneal conditions.

The primary goal will be achieved by using optical coherence tomography (OCT) to:

  1. Develop an OCT-based system to classify and evaluate corneal-shape irregularities.
  2. Develop OCT metrics for more sensitive detection of keratoconus progression.
  3. Develop OCT-and-topography guided phototherapeutic keratectomy (PTK) for irregular corneas.

Eligibility

Inclusion Criteria:

GROUP A:

  • Keratoconus:
    1. CDVA ≥ 20/25 in the better eye; and both of the following in the worse eye
    2. Topography characteristic of keratoconus or pellucid marginal degeneration
  • Contact lens-related corneal warpage:
    1. Contact lens use; and
    2. Topography irregularities
  • Dry eye:
    1. Symptoms of dry eye documented by Ocular Surface Disease Index (OSDI) questionnaire score ≥ 30; and
    2. Topography irregularities
    3. Presence of punctate epithelial erosion on exam with surface staining
    4. Aqueous deficiency or evaporative dry eye
  • Epithelial basement membrane dystrophy (EBMD):
    1. Negative corneal fluorescein staining; and
    2. Corneal opacities; and
    3. Topography irregularities
  • Stromal addition or subtraction:
    1. Scars; or
    2. Salzmann's degeneration; or
    3. Stromal dystrophies; or
    4. Complication (visual complaints) after LASIK or photorefractive keratectomy (PRK)
  • Stromal distortion:
    1. Radial keratectomy (RK); or
    2. Corneal transplants.
  • Normal controls:
    1. Healthy eyes with no previous eye procedures/surgeries.

GROUP B:

        Participants will be selected from the keratoconus population in Group A based on
        topography findings.
        GROUP C:
        Participants will be selected from the stromal addition/subtraction and stromal distortion
        populations of Group A if they have vision primarily limited by scars, dystrophy, or high
        astigmatism that could benefit from PTK.
        Exclusion Criteria (all groups):
          -  Inability to give informed consent.
          -  Inability to maintain fixation for OCT imaging.
          -  Inability to commit to required study visits.
          -  Eyes with concurrent cataract, retinal disease, glaucoma, or other eye conditions that
             may limit the visual outcome after surgery.
          -  Previous corneal surgeries if considered as a keratoconus participant.
          -  Pregnancy or breastfeeding.

Study details
    Keratoconus
    Corneal Opacity
    Corneal Dystrophy

NCT03504800

Oregon Health and Science University

8 March 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.